Title:
IMIDAZOLOPYRIDAZINE OR PYRAZOLOPYRIMIDINE COMPOUNDS AND COMPOSITIONS
Document Type and Number:
WIPO Patent Application WO/2022/156657
Kind Code:
A1
Abstract:
Provided herein are novel compounds (e.g., Formula I or II), pharmaceutical compositions, and methods of using related to Tyrosine kinase 2 (TYK2). The compounds herein are typically TYK2 inhibitors, which can be used for treating a variety of diseases or disorders, such as an autoimmune disorder or an inflammatory disorder, e.g., psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, inflammatory bowel disease, and/or systemic lupus erythematosus.
Inventors:
CHENG DAI (CN)
ZENG SEN (CN)
YUE QIMING (CN)
XIE ZEQIANG (CN)
ZENG SEN (CN)
YUE QIMING (CN)
XIE ZEQIANG (CN)
Application Number:
PCT/CN2022/072472
Publication Date:
July 28, 2022
Filing Date:
January 18, 2022
Export Citation:
Assignee:
ANRUI BIOMEDICAL TECH GUANGZHOU CO LTD (CN)
International Classes:
A61K31/5025; C07D487/14; A61K31/5383; A61P29/00; A61P37/00; C07D487/04
Domestic Patent References:
| WO2021162942A1 | 2021-08-19 | |||
| WO2021162944A1 | 2021-08-19 | |||
| WO2015089143A1 | 2015-06-18 | |||
| WO2019023468A1 | 2019-01-31 | |||
| WO2020055636A1 | 2020-03-19 | |||
| WO2020081508A1 | 2020-04-23 | |||
| WO2020154474A1 | 2020-07-30 | |||
| WO2020163778A1 | 2020-08-13 |
Attorney, Agent or Firm:
SHANGHAI DIANSHI PARTNERS, P.C. (CN)
Download PDF: